Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma
Introduction Proton craniospinal irradiation (pCSI) is a treatment option for leptomeningeal disease (LMD), which permits whole neuroaxis treatment while minimizing toxicity. Despite this, patients inevitably experience progression. Adding systemic therapy to pCSI may improve outcomes. Methods In th...
| 出版年: | Journal of Immunotherapy and Precision Oncology |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Innovative Healthcare Institute
2024-02-01
|
| 主題: | |
| オンライン・アクセス: | https://jipo.org/doi/pdf/10.36401/JIPO-23-20 |
